The House Oversight Committee’s ongoing probe into the Justice Department’s handling and public release of Jeffrey Epstein files continues to drive congressional testimony activity into mid-2026. Bill Gates completed a closed-door transcribed interview on June 10, while former Attorney General Pam Bondi appeared in late May; lawmakers have since signaled interest in acting Attorney General Todd Blanche and Vice President JD Vance. These developments occur against the backdrop of the Epstein Files Transparency Act and internal administration tensions highlighted in recent reporting. Trader pricing on specific high-profile names remains low, reflecting procedural focus on DOJ officials and the committee’s pattern of voluntary or subpoenaed interviews rather than broad public hearings involving former presidents, foreign figures, or other associates. Resolution hinges on further committee votes or announcements through the summer.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$62,615 Vol.
Jun 30, 2026
Lord Peter Mandelson
1%
Elon Musk
<1%
Ex-Prince Andrew
<1%
Ghislaine Maxwell
<1%
Donald Trump
<1%
$62,615 Vol.
Lord Peter Mandelson
$2,938 Vol.
1%
Elon Musk
$1,374 Vol.
<1%
Ex-Prince Andrew
$1,334 Vol.
<1%
Ghislaine Maxwell
$5,822 Vol.
<1%
Donald Trump
$1,236 Vol.
<1%
This market will resolve to "Yes" if the listed individual provides testimony about Jeffrey Epstein before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.The House Oversight Committee’s ongoing probe into the Justice Department’s handling and public release of Jeffrey Epstein files continues to drive congressional testimony activity into mid-2026. Bill Gates completed a closed-door transcribed interview on June 10, while former Attorney General Pam Bondi appeared in late May; lawmakers have since signaled interest in acting Attorney General Todd Blanche and Vice President JD Vance. These developments occur against the backdrop of the Epstein Files Transparency Act and internal administration tensions highlighted in recent reporting. Trader pricing on specific high-profile names remains low, reflecting procedural focus on DOJ officials and the committee’s pattern of voluntary or subpoenaed interviews rather than broad public hearings involving former presidents, foreign figures, or other associates. Resolution hinges on further committee votes or announcements through the summer.
This market will resolve to "Yes" if the listed individual provides testimony about Jeffrey Epstein before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.
Market Opened: Feb 2, 2026, 2:59 PM ET
Volume
$62,615End Date
Jun 30, 2026Market Opened
Feb 2, 2026, 2:59 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the listed individual provides testimony about Jeffrey Epstein before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.The House Oversight Committee’s ongoing probe into the Justice Department’s handling and public release of Jeffrey Epstein files continues to drive congressional testimony activity into mid-2026. Bill Gates completed a closed-door transcribed interview on June 10, while former Attorney General Pam Bondi appeared in late May; lawmakers have since signaled interest in acting Attorney General Todd Blanche and Vice President JD Vance. These developments occur against the backdrop of the Epstein Files Transparency Act and internal administration tensions highlighted in recent reporting. Trader pricing on specific high-profile names remains low, reflecting procedural focus on DOJ officials and the committee’s pattern of voluntary or subpoenaed interviews rather than broad public hearings involving former presidents, foreign figures, or other associates. Resolution hinges on further committee votes or announcements through the summer.
This market will resolve to "Yes" if the listed individual provides testimony about Jeffrey Epstein before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.
Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public.
A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify.
The resolution source for this market will be a consensus of credible reporting.
Volume
$62,615End Date
Jun 30, 2026Market Opened
Feb 2, 2026, 2:59 PM ETResolver
0x65070BE91...The House Oversight Committee’s ongoing probe into the Justice Department’s handling and public release of Jeffrey Epstein files continues to drive congressional testimony activity into mid-2026. Bill Gates completed a closed-door transcribed interview on June 10, while former Attorney General Pam Bondi appeared in late May; lawmakers have since signaled interest in acting Attorney General Todd Blanche and Vice President JD Vance. These developments occur against the backdrop of the Epstein Files Transparency Act and internal administration tensions highlighted in recent reporting. Trader pricing on specific high-profile names remains low, reflecting procedural focus on DOJ officials and the committee’s pattern of voluntary or subpoenaed interviews rather than broad public hearings involving former presidents, foreign figures, or other associates. Resolution hinges on further committee votes or announcements through the summer.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions